Hopen Life Science Ventures Expands Leadership Team with Addition of Michael Fulton, M.D. as Managing Director; Opens Cleveland, Ohio Office to Strengthen Midwest Reach

Cleveland, OH (September 18, 2012) – Hopen Life Science Ventures, a Midwest-based venture capital firm, is pleased to announce the addition of Michael Fulton, M.D. as a managing director. Dr. Fulton has over 20 years experience in the life sciences, including 14 years as a successful early-stage investor and entrepreneur. Prior to joining Hopen, he served in the roles of founder, director, and CEO at start-up medical device and services companies, including Lanx, Inc., the second largest private company in the $7 billion spinal implant market. As CEO of Lanx, he built the organization from a single employee, pre-revenue start-up into a rapidly growing international corporation with over 200 employees and a complete portfolio of spinal fusion products.

Dr. Fulton also co-founded, played a key leadership role, and served on the board of directors of ProNerve, LLC, one of the top five companies in the $1.4 billion intraoperative monitoring market. He is an inventor of multiple neurosurgical and spinal devices, with over 50 issued and pending U.S. and international patents. Dr. Fulton received his B.A. from Northwestern University, his M.D. from Cornell University Medical College, and completed two years of neurosurgery residency at the Cleveland Clinic.

“We believe it takes more than just capital to build strong life science start-ups,” said Michael Jandernoa, a managing general partner at Hopen. “The addition of Dr. Fulton will complement Hopen co-founder and managing director Mark Olesnavage and the existing team in Michigan. We are excited to have attracted a successful investor and entrepreneur of Mike’s caliber to launch Hopen’s expansion into Ohio.”

Dr. Fulton is based in Cleveland and leads all activities related to sourcing new investment opportunities for the Fund in the Ohio region. With the Cleveland office officially open, he has already begun meeting with management teams, and other members of Ohio’s entrepreneurial ecosystem.

“I was thrilled to join the accomplished Hopen team and to open our new office in an area with a rich healthcare tradition,” Dr. Fulton commented. “The Cleveland Clinic, Ohio State University, BioEnterprise, University Hospitals, JumpStart, and the extended community of healthcare investors and supporting infrastructure, all made Ohio the logical choice for our expansion. I look forward to working with entrepreneurs in Ohio and throughout the Midwest to bring innovative and cost-effective healthcare solutions to market.”

About Hopen Life Science Ventures

Hopen Life Science Ventures (www.hopenls.com) is a Midwest-based venture capital firm that invests in exceptional early- to mid-stage life science opportunities. With offices in Michigan and Ohio, the Firm is very active in the Midwest, a geographic region steeped in life science innovation, but traditionally underserved with capital. The Hopen team includes investment professionals with extensive prior experience launching and ramping private and public life science companies. Hopen manages over $65 million of capital and is actively making new investments via Hopen Life Science Fund II.

Piper Fields, Hopen Life Science Ventures